Viewing Study NCT06869551

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-05-28 @ 5:28 AM
Study NCT ID: NCT06869551
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Sponsor: Bristol-Myers Squibb
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Juvenile Psoriatic Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Juvenile Psoriatic Arthritis (JPsA) View
None Juvenile Idiopathic Arthritis (JIA) View
None Pediatric PsA View
None Deucravacitinib View
None BMS-986165 View